Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis
Open Access
- 18 January 2012
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 307 (3), 294-303
- https://doi.org/10.1001/jama.2011.2029
Abstract
Postoperative venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is an important safety issue in acute care hospitals.1 Quiz Ref ID Without prophylaxis, VTE (both symptomatic and asymptomatic) is the most frequent surgical adverse event after infections.2 In the absence of prophylactic therapy, the incidence of postoperative VTE is particularly high after orthopedic surgery: the incidence of DVT (as detected by screening tests) varies from 42% to 57% after hip arthroplasty and from 41% to 85% after knee arthoplasty; the incidence of pulmonary embolism varies from 0.9% to 28% after hip arthroplasty and from 1.5% to 10% after knee arthroplasty.3 Although asymptomatic VTE is more common than symptomatic VTE, available data demonstrate that symptomatic VTE is clinically important, while the clinical relevance of asymptomatic VTE is less clear.3-5Keywords
This publication has 29 references indexed in Scilit:
- Preventing Postsurgical Venous Thromboembolism: Pharmacological ApproachesSeminars in Thrombosis and Hemostasis, 2011
- Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplastyInternational Orthopaedics, 2010
- Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)Journal of Thrombosis and Haemostasis, 2010
- A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgeryThrombosis and Haemostasis, 2010
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee ReplacementNew England Journal of Medicine, 2009
- AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging studyJournal of Thrombosis and Haemostasis, 2009
- Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplastyThrombosis and Haemostasis, 2009
- Mechanical prophylaxis of deep-vein thrombosis after total hip replacementThe Journal of Bone and Joint Surgery. British volume, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002